Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lagercrantz Group in connection with acquisition of Ideso
Mandate

Vinge advises Lagercrantz Group in connection with acquisition of Ideso

March 20, 2012

Vinge has advised the Lagerkrantz Group in connection with the acquisition of 90% of the shares in the Finnish company, Idesco. Idesco develops and sells products based on RFID (radio frequency identification) technology. Idesco is the market leader in Finland within access control in relation to products for high security, industrial and commercial properties and the company also conducts operations  within the industrial identification solutions sector. 

Vinge’s team consisted of responsible partner Johan Winnerblad and associates Louise Markgren and Karl Hahtovirta.

Related

Vinge advises OsteoCentric on the public offer for Integrum

 OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

 Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

 Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025